News: Portfolio 2007

TetraLogic Pharmaceuticals Appoints Dr. Andrew Pecora to Its Board of Directors

(continued)

Among his numerous other professional positions, Dr. Pecora is co-Founder and co-managing partner of Northern New Jersey Cancer Associates. He is also founder and Chairman of Amorcyte, Inc., a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, and Co-founder, Chairman and Chief Executive Officer of Progenitor Cell Therapy, LLC, a client-based cell therapy services company supporting the development and commercialization of cellular therapies. Dr. Pecora also currently serves as Editor of the American Society of Blood and Marrow Transplantation e-News; a Member of the Medical Advisory Board of The Bone Marrow Foundation; and Member, New Jersey Working Group to Improve Outcomes in Cancer Patients.

Dr. Pecora has authored or co-authored numerous articles, abstracts, books, chapters and monographs and is a frequent lecturer in the field of cancer. He received his Bachelor of Science degree in Biology from Seton Hall University and his Medical Degree from the University of Medicine and Dentistry of New Jersey. He completed both his postdoctoral internship in internal medicine as well as his residency in the Department of Internal Medicine at The New York Hospital, located in New York, NY, and completed a fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center, also in New York. He is licensed to practice in both New Jersey and New York.

Page: 1 2 3